Myelodysplastic SyndromesHepcidinsAnemia, RefractoryAnemia, Refractory, with Excess of BlastsSyndromeAntimicrobial Cationic PeptidesLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, AcuteChromosomes, Human, Pair 5Leukemia, MyeloidAzacitidineAnemia, SideroblasticIron OverloadBone MarrowIronChromosome AberrationsKaryotypingMonosomyThalidomidePreleukemiaMyeloproliferative DisordersMyelodysplastic-Myeloproliferative DiseasesPancytopeniaAnemia, AplasticChromosomes, Human, Pair 7Cytogenetic AnalysisPrognosisBone Marrow CellsAcute DiseaseLeukemiaChromosome DeletionGranulocyte Precursor CellsTreatment OutcomeAnemiaNeoplasms, Second PrimaryErythropoietinBone Marrow DiseasesHematopoietic Stem Cell TransplantationTrisomyAntimetabolites, AntineoplasticErythropoiesisCytogeneticsChelation TherapyErythrocyte TransfusionHematologic AgentsBlood TransfusionHemochromatosisFerritinsTransplantation, HomologousHematopoietic Stem CellsSurvival AnalysisAntigens, CD34MutationDown SyndromeCytarabineMetabolic Syndrome XRemission InductionBlast CrisisHematopoiesisTransplantation ConditioningBone Marrow ExaminationIron Chelating AgentsThrombocytopeniaBone Morphogenetic Protein 6Blood Cell CountVidarabineSurvival RateDisease ProgressionSweet SyndromeIn Situ Hybridization, FluorescenceAnemia, MacrocyticGranulocyte Colony-Stimulating FactorHematinicsHematologic DiseasesChromosomes, Human, Pair 8Antineoplastic AgentsCore Binding Factor Alpha 2 SubunitRetrospective StudiesChromosome DisordersHaploinsufficiencyKaryotypeErythroid Precursor CellsTranslocation, GeneticAnemia, Iron-DeficiencyErythroblastsChromosomes, Human, Pair 20Hematologic NeoplasmsPrimary MyelofibrosisCation Transport ProteinsLeukemia, Myelomonocytic, AcuteFlow CytometryErythroid CellsBone Marrow TransplantationRisk FactorsDNA Modification MethylasesHemoglobinuria, ParoxysmalImmunophenotypingAntilymphocyte SerumBusulfanFatal Outcome